Cargando…

91 Efficacy of Venom Immunotherapy Given Every 3 or 4 Months. A Direct Prospective Comparison With the Conventional Regimen

BACKGROUND: The standard venom immunotherapy involves the administration of the maintenance dose every 4 to 6 weeks. This regimen may have compliance problem especially in the long term, thus extended intervals have been proposed. We prospectively compared the efficacy of 3- or 4-month extended main...

Descripción completa

Detalles Bibliográficos
Autores principales: Simioni, Livio, Vianello, Alberto, Bonadonna, Patrizia, Marcer, Guido, Severino, Maurizio, Pagani, Mauro, Morlin, Luca, Crivellaro, Mariangiola, Passalacqua, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization Journal 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512817/
http://dx.doi.org/10.1097/01.WOX.0000411836.07871.d2
_version_ 1782251808839696384
author Simioni, Livio
Vianello, Alberto
Bonadonna, Patrizia
Marcer, Guido
Severino, Maurizio
Pagani, Mauro
Morlin, Luca
Crivellaro, Mariangiola
Passalacqua, Giovanni
author_facet Simioni, Livio
Vianello, Alberto
Bonadonna, Patrizia
Marcer, Guido
Severino, Maurizio
Pagani, Mauro
Morlin, Luca
Crivellaro, Mariangiola
Passalacqua, Giovanni
author_sort Simioni, Livio
collection PubMed
description BACKGROUND: The standard venom immunotherapy involves the administration of the maintenance dose every 4 to 6 weeks. This regimen may have compliance problem especially in the long term, thus extended intervals have been proposed. We prospectively compared the efficacy of 3- or 4-month extended maintenance dose and the conventional regimen. METHODS: Patients receiving immunotherapy of a single venom were offered the delayed maintenance dose, and were then followed-up for field re-stings. Only the re-stings by the insect for which the patients received immunotherapy were considered. A matched group of patients receiving the conventional maintenance were used for comparison, by univariate and multivariate analysis. RESULTS: Fifty-two patients (44 male, 8 female, mean age 52 years) were certainly re-stung on 113 occasions by the insect for which they were receiving immunotherapy. 90 re-stings occurred during the 3- month maintenance and 23 during the 4-month maintenance. The control group, on conventional protocol with one single venom, included 103 patients (79 male, 24 female, mean age 41 years) certainly re-stung on 160 occasions by the specific insect. The rate of re-sting without reaction was 97% in the delayed maintenance and 82% in the conventional group with a significant difference in favour of the former (P = 0.01). None of the variables considered resulted predictive for systemic reactions by logistic regression analysis CONCLUSIONS: The delayed maintenance dose approach is al least as effective and safe as the conventional one. The 4-month maintenance seems to be the best option in term of convenience and economic save.
format Online
Article
Text
id pubmed-3512817
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher World Allergy Organization Journal
record_format MEDLINE/PubMed
spelling pubmed-35128172012-12-21 91 Efficacy of Venom Immunotherapy Given Every 3 or 4 Months. A Direct Prospective Comparison With the Conventional Regimen Simioni, Livio Vianello, Alberto Bonadonna, Patrizia Marcer, Guido Severino, Maurizio Pagani, Mauro Morlin, Luca Crivellaro, Mariangiola Passalacqua, Giovanni World Allergy Organ J Abstracts of the XXII World Allergy Congress BACKGROUND: The standard venom immunotherapy involves the administration of the maintenance dose every 4 to 6 weeks. This regimen may have compliance problem especially in the long term, thus extended intervals have been proposed. We prospectively compared the efficacy of 3- or 4-month extended maintenance dose and the conventional regimen. METHODS: Patients receiving immunotherapy of a single venom were offered the delayed maintenance dose, and were then followed-up for field re-stings. Only the re-stings by the insect for which the patients received immunotherapy were considered. A matched group of patients receiving the conventional maintenance were used for comparison, by univariate and multivariate analysis. RESULTS: Fifty-two patients (44 male, 8 female, mean age 52 years) were certainly re-stung on 113 occasions by the insect for which they were receiving immunotherapy. 90 re-stings occurred during the 3- month maintenance and 23 during the 4-month maintenance. The control group, on conventional protocol with one single venom, included 103 patients (79 male, 24 female, mean age 41 years) certainly re-stung on 160 occasions by the specific insect. The rate of re-sting without reaction was 97% in the delayed maintenance and 82% in the conventional group with a significant difference in favour of the former (P = 0.01). None of the variables considered resulted predictive for systemic reactions by logistic regression analysis CONCLUSIONS: The delayed maintenance dose approach is al least as effective and safe as the conventional one. The 4-month maintenance seems to be the best option in term of convenience and economic save. World Allergy Organization Journal 2012-02-17 /pmc/articles/PMC3512817/ http://dx.doi.org/10.1097/01.WOX.0000411836.07871.d2 Text en Copyright © 2012 by World Allergy Organization
spellingShingle Abstracts of the XXII World Allergy Congress
Simioni, Livio
Vianello, Alberto
Bonadonna, Patrizia
Marcer, Guido
Severino, Maurizio
Pagani, Mauro
Morlin, Luca
Crivellaro, Mariangiola
Passalacqua, Giovanni
91 Efficacy of Venom Immunotherapy Given Every 3 or 4 Months. A Direct Prospective Comparison With the Conventional Regimen
title 91 Efficacy of Venom Immunotherapy Given Every 3 or 4 Months. A Direct Prospective Comparison With the Conventional Regimen
title_full 91 Efficacy of Venom Immunotherapy Given Every 3 or 4 Months. A Direct Prospective Comparison With the Conventional Regimen
title_fullStr 91 Efficacy of Venom Immunotherapy Given Every 3 or 4 Months. A Direct Prospective Comparison With the Conventional Regimen
title_full_unstemmed 91 Efficacy of Venom Immunotherapy Given Every 3 or 4 Months. A Direct Prospective Comparison With the Conventional Regimen
title_short 91 Efficacy of Venom Immunotherapy Given Every 3 or 4 Months. A Direct Prospective Comparison With the Conventional Regimen
title_sort 91 efficacy of venom immunotherapy given every 3 or 4 months. a direct prospective comparison with the conventional regimen
topic Abstracts of the XXII World Allergy Congress
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512817/
http://dx.doi.org/10.1097/01.WOX.0000411836.07871.d2
work_keys_str_mv AT simionilivio 91efficacyofvenomimmunotherapygivenevery3or4monthsadirectprospectivecomparisonwiththeconventionalregimen
AT vianelloalberto 91efficacyofvenomimmunotherapygivenevery3or4monthsadirectprospectivecomparisonwiththeconventionalregimen
AT bonadonnapatrizia 91efficacyofvenomimmunotherapygivenevery3or4monthsadirectprospectivecomparisonwiththeconventionalregimen
AT marcerguido 91efficacyofvenomimmunotherapygivenevery3or4monthsadirectprospectivecomparisonwiththeconventionalregimen
AT severinomaurizio 91efficacyofvenomimmunotherapygivenevery3or4monthsadirectprospectivecomparisonwiththeconventionalregimen
AT paganimauro 91efficacyofvenomimmunotherapygivenevery3or4monthsadirectprospectivecomparisonwiththeconventionalregimen
AT morlinluca 91efficacyofvenomimmunotherapygivenevery3or4monthsadirectprospectivecomparisonwiththeconventionalregimen
AT crivellaromariangiola 91efficacyofvenomimmunotherapygivenevery3or4monthsadirectprospectivecomparisonwiththeconventionalregimen
AT passalacquagiovanni 91efficacyofvenomimmunotherapygivenevery3or4monthsadirectprospectivecomparisonwiththeconventionalregimen